Article Details
Retrieved on: 2021-03-11 18:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
March 11, 2021 (Investorideas.com Newswire) An update on two of Can-Fite BioPharma's studies involving its lead drug candidate Piclidenoson is ...
Article found on: www.investorideas.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here